#CPHI22: An­nu­al re­port shows ‘mod­er­ate out­look’ and fo­cus on mR­NA

As the top com­pa­nies and ex­ec­u­tives in the man­u­fac­tur­ing in­dus­try gath­er in Ger­many for the an­nu­al CPHI con­fer­ence, the an­nu­al re­port, which polled 400 in­dus­try ex­ecs from around the world, sheds a light on the prospects of the man­u­fac­tur­ing and biotech in­dus­tries.

The re­port states that ex­ec­u­tives are pos­i­tive go­ing in­to next year, with on­ly 19% hav­ing a neg­a­tive out­look. But 59% stat­ed that the out­look is mod­er­ate. The re­port states that the “bot­tom has now come in for biotech val­u­a­tions and fund­ing.” Val­u­a­tions need a cor­rec­tion and fund­ing may need to be paused to wait for bet­ter con­di­tions, it says.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER